Home Tags Pharmaceutical
Opioid overdose deaths are highest in places where pharma spends the most on marketing, a new study finds
Researchers at the University of Pittsburgh launched a study to figure out if there's a link between the money that drugmakers spend on opioid marketing and drug-related deaths.
On Thursday, pharma giant Eli Lilly and Co. announced positive results in a mid-stage trial for its experimental new diabetes drug. The company's stock was up 3% in afternoon trading.
Pfizer’s long-serving CEO, Ian Read, is standing down and being replaced by his chief operating officer
Read, who has been at the helm of the firm since 2010, will stand down on January 1, the company announced Monday. He will be replaced by Pfizer's chief operating officer, Albert Bourla.
A startup with ties to Bayer has inked a $122 million deal to make lab-grown marijuana — and it’s eyeing the pharma industry
Boston-based startup Ginkgo Bioworks will use Cronos' labs to produce synthetic marijuana compounds, many of which "have the potential to be valuable in a range of pharmaceutical applications."
Stanford researchers are figuring out how ketamine fights depression — and why the drug has been called ‘the most important discovery in h...
A new Stanford study is the first to illuminate how ketamine works in the brain to alleviate depression. The research suggests that the drug engages the opioid system — the same one that's activated by opioid painkillers — in addition to affecting the glutamate system.
DNA-testing company 23andMe has signed a $300 million deal with a drug giant. Here’s how to delete your data if that freaks you out.
Genetics-testing companies like Ancestry and 23andMe can — and frequently do — sell your data to drugmakers. A $300 million deal between 23andMe and the pharmaceutical giant GlaxoSmithKline is the latest example. If that has you thinking about how these companies use your data, here's how to delete it.
Pharmaceutical companies are backing away from a growing threat that could kill 10 million people a year by 2050
Novartis last week joined a number of large pharma companies that are dropping their antibiotics research projects. As superbugs become a growing problem, here's a look at what drugmakers have in store to combat this issue.
Doctors are calling out a new drug that helps people with addiction for costing more than $1,700 a week — while a generic costs just $1
Two months after it became the first federally approved drug of its kind to treat addiction, doctors are calling out Lucemyra, a new branded medication to treat opioid withdrawal, for costing $1,737 more per week than a similar generic drug.
One of the world’s largest tobacco giants is teaming up with Snoop Dogg’s VC firm to invest in medical cannabis research
Imperial Brands, through its venture arm, participated in a Series A fundraising round for Oxford Cannabinoid Technologies (OCT), along with Snoop Dogg's cannabis-focused venture firm, Casa Verde Capital.
A drug derived from marijuana has become the first to win federal approval, and experts predict an avalanche effect
GW Pharmaceutical's drug Epidiolex just became the first marijuana-based drug to win FDA approval. Studies suggest its active ingredient, CBD, reduces seizures in two rare types of epilepsy. The approval will likely galvanize future marijuana research.